A phase Ib study of oral panobinostat (LBH589) administered with 5-azacitidine (5-Aza) in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or acute myeloid leukemia (AML)

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 28; no. 15_suppl; p. TPS282
Main Authors Ottmann, O. G., Fenaux, P., Lübbert, M., DeAngelo, D. J., Garcia-Manero, G., Bhalla, K. N., Sekeres, M. A., Lüdicke, F., Weber, H. J., Winiger, I. J.
Format Journal Article
LanguageEnglish
Published 20.05.2010
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2010.28.15_suppl.tps282